LONG TERM COSTS AND OUTCOMES IN PSORIATIC ARTHRITIS PATIENTS NOT RESPONDING TO CONVENTIONAL THERAPY TREATED WITH TUMOR NECROSIS FACTOR INHIBITORS: THE EXTENSION OF PSORIATIC ARTHRITIS COST EVALUATION (PACE) STUDY

被引：1
|
作者：
Cortesi, P. A. [1 ]
Olivieri, I [2 ,3 ,4 ,5 ]
de Portu, S. [6 ]
Salvarani, C. [7 ]
Cauli, A. [8 ]
Lubrano, E. [9 ]
Spadaro, A. [10 ]
Cantini, F. [11 ]
Cutro, M. [2 ,3 ,4 ,5 ]
Mathieu, A.
Matucci-Cerinic, M. [12 ]
Pappone, N. [13 ]
Punzi, L. [14 ]
Scarpa, R. [15 ]
Mantovani, L. G. [15 ]
机构：
[1] Univ Milano Bicocca, Monza, Italy
[2] San Carlo Hosp Potenza, Potenza, Italy
[3] Madonna Grazie Hosp, Potenza, Italy
[4] San Carlo Hosp Potenza, Matera, Italy
[5] Madonna Grazie Hosp, Matera, Italy
[6] Medtron Int Sarl, Tolochenaz, Switzerland
[7] Arcispedale S Maria Nuova, Reggio Emilia, Italy
[8] Univ Cagliari, Monserrato, Italy
[9] Univ Molise, Campobasso, Italy
[10] Univ Roma La Sapienza, I-00185 Rome, Italy
[11] Prato Hosp, Prato, Italy
[12] Univ Florence, Florence, Italy
[13] Fdn Maugeri IRCCS, Telese Terme, Italy
[14] Univ Padua, Padua, Italy
[15] Univ Naples Federico II, Naples, Italy
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 07期
关键词：
D O I：
10.1016/j.jval.2013.08.1507
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A566 / A566
页数：1
相关论文
共 50 条
  • [41] COMPARISON OF LONG-TERM DRUG SURVIVAL OF TUMOR NECROSIS FACTOR INHIBITORS IN PATIENTS WITH RHEUMATOID ARTHRITIS, ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS: A SINGLE CENTER TURKISH EXPERIENCE OVER A DECADE
    Can, G.
    Capar, S.
    Cetin, P.
    Solmaz, D.
    Kenar, G.
    Yarkan, H.
    Akar, S.
    Birlik, M.
    Sari, I.
    Onen, F.
    Akkoc, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1275 - 1276
  • [42] EFFECTIVENESS AND PERSISTENCE OF THE FIRST TUMOR NECROSIS FACTOR INHIBITOR IN PORTUGUESE PSORIATIC ARTHRITIS PATIENTS
    Vieira-Sousa, E.
    Eusebio, M.
    Avila-Ribeiro, P.
    Khmelinskii, N.
    Machado, R.
    Rocha, T. M.
    Bernardes, M.
    Santos-Faria, D.
    Leite Silva, J.
    Santos, H.
    Miguel, G.
    Carvalho, P.
    Costa, T.
    Teixeira, L.
    Meirinhos, T.
    Nero, P.
    Santos, M. J.
    VALUE IN HEALTH, 2017, 20 (09) : A527 - A527
  • [43] Depression and Insomnia in Patients With Psoriasis and Psoriatic Arthritis Taking Tumor Necrosis Factor Antagonists
    Wu, Chun-Ying
    Chang, Yun-Ting
    Juan, Chao-Kuei
    Shen, Jui-Lung
    Lin, Yu-Pu
    Shieh, Jeng-Jer
    Liu, Han-Nan
    Chen, Yi-Ju
    MEDICINE, 2016, 95 (22)
  • [44] Long Term Outcomes In Psoriatic Arthritis 2; A Prospective Multicentre Observational Study Of Work Disability In Psoriatic Arthritis: First Report Of The Clinical and Socioeconomic Associations Of Work Disability In Psoriatic Arthritis
    Tillett, William
    Shaddick, Gavin
    Askari, Ayman
    Cooper, Annie
    Creamer, Paul
    Clunie, Gavin
    Helliwell, Philip S.
    Kay, Lesley
    Korendowych, Eleanor
    Lane, Suzanne
    Packham, Jonathon
    Shaban, Ragai
    Williamson, Lyn
    deVries, Corinne
    McHugh, Neil
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S134 - S134
  • [45] Serious infections in patients with rheumatoid arthritis and psoriatic arthritis treated with tumour necrosis factor inhibitors: data from register linkage of the NOR-DMARD study
    Christensen, Ingrid Egeland
    Lillegraven, Siri
    Mielnik, Pawel
    Bakland, Gunnstein
    Loli, Liz
    Sexton, Joe
    Uhlig, Till
    Kvien, Tore K.
    Provan, Sella A.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (03) : 398 - 401
  • [46] Tumor Necrosis Factor-α Receptor 2 Polymorphisms and Response to TNF Inhibitor Therapy in Patients with Psoriatic Arthritis
    Rasheed, Sarah
    Dunlap, MacKenzie
    Harvey, Jennifer
    Brennan, Connery
    Jin, Yuxuan
    Chandrasekharan, Unnikrishnan
    Husni, M. Elaine
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [47] DATA VISUALIZATION OF TREATMENT PATTERNS OF MEDICARE PSORIATIC ARTHRITIS PATIENTS WHO INITIATE TUMOR NECROSIS FACTOR THERAPY
    Baser, O.
    Wang, L.
    Xie, L.
    Yuce, H.
    VALUE IN HEALTH, 2012, 15 (04) : A34 - A34
  • [48] Relation Between Fatigue and ACR Response in Patients With Psoriatic Arthritis Treated With Tumor Necrosis Factor Inhibitor Therapy: A Population-based Cohort Study
    Jorgensen, Tanja Schjodt
    Skougaard, Marie
    Hansen, Rebekka Lund
    Ballegaard, Christine
    Mease, Philip
    Strand, Vibeke
    Dreyer, Lene
    Kristensen, Lars Erik
    JOURNAL OF RHEUMATOLOGY, 2021, 48 (06) : 829 - 835
  • [49] Impact of Comorbidities on Tumor Necrosis Factor Inhibitor Therapy in Psoriatic Arthritis: A Population-Based Cohort Study
    Ballegaard, Christine
    Hojgaard, Pil
    Dreyer, Lene
    Cordtz, Rene
    Jorgensen, Tanja Schjodt
    Skougaard, Marie
    Tarp, Simon
    Kristensen, Lars Erik
    ARTHRITIS CARE & RESEARCH, 2018, 70 (04) : 592 - 599
  • [50] LONG-TERM EFFICACY OF USTEKINUMAB TREATMENT IN PATIENTS AFFECTED BY PSORIATIC ARTHRITIS PREVIOUSLY TREATED WITH TNF INHIBITORS
    Chimenti, M. S.
    Triggianese, P.
    Ortolan, A.
    Tonelli, M.
    Talamonti, M.
    Costa, L.
    Caso, F.
    Teoli, M.
    Galluzzo, M.
    Ramonda, R.
    Scarpa, R.
    Punzi, L.
    Perricone, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 605 - 606
12345